Files in this item
Author | Bulumulle, Anushi | |
Author | Brody, Heather | |
Author | Macherla, Shravanti | |
Author | Walker, Paul R. | |
Author | Sehgal, Kartik | |
Author | Gill, Ritu R. | |
Author | Qilleri, Aleksandra | |
Author | McDonald, Danielle C. | |
Author | Cherry, Cynthia R. | |
Author | Shea, Meghan | |
Author | Huberman, Mark S. | |
Author | VanderLaan, Paul A. | |
Author | Weiss, Glen J. | |
Author | Costa, Daniel B. | |
Author | Rangachari, Deepa | |
Date Accessioned | 2022-09-26T18:01:38Z | |
Date Available | 2022-09-26T18:01:38Z | |
Date of Issue | 2021 | |
ISSN | 1525-7304 | |
Identifier (URI) | http://hdl.handle.net/10342/11327 | |
Language | en_US | en_US |
Subject | Extended-interval dosing | en_US |
Subject | Immune-related adverse event | en_US |
Subject | Patient-physician preference | en_US |
Title | Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Nonesmall-cell Lung Cancer | en_US |
Type | Article | en_US |
Identifier (DOI) | 10.1016/j.cllc.2020.05.028 | |
Journal Name | Clinical Lung Cancer | en_US |
Journal Volume | 22 | en_US |
Journal Issue | 3 | en_US |
Article Pages | e379-e389 | en_US |